Metformin synergizes with BCL-XL/BCL-2 inhibitor ABT-263 to...

  • Main
  • 2017 / 05
  • Metformin synergizes with BCL-XL/BCL-2 inhibitor ABT-263 to...
Molecular Cancer Therapeutics 2017 / 05

Metformin synergizes with BCL-XL/BCL-2 inhibitor ABT-263 to induce apoptosis specifically in p53-defective cancer cells

Li, Xinzhe, Li, Bo, Ni, Zhenhong, Zhou, Peng, Wang, Bin, He, Jintao, Xiong, Haojun, Yang, Fan, Wu, Yaran, Lyu, Xilin, Zhang, Yan, Zeng, Yijun, Lian, Jiqin, He, Fengtian
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-16-0763
Date:
May, 2017
File:
PDF, 7.26 MB
english, 2017
Conversion to is in progress
Conversion to is failed